TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has shared an update.
ASKA Pharmaceutical Holdings Co., Ltd. has received a statement of intent from Dalton Investments and associated entities to potentially purchase up to 30% of the company’s shares. This move could lead to proposals aimed at enhancing corporate value and shareholder interests, with the possibility of delisting the company if deemed beneficial. The company’s board plans to review the terms of this large-scale purchase and will provide necessary information to shareholders for consideration.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates within the pharmaceutical industry, focusing on the development and distribution of medical products. The company is headquartered in Minato-ku, Tokyo, and is listed on the Tokyo Stock Exchange under the ticker 4886.
Average Trading Volume: 37,884
Technical Sentiment Signal: Buy
Current Market Cap: Yen61.45B
Find detailed analytics on 4886 stock on TipRanks’ Stock Analysis page.